ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,552,799, issued on Feb. 17, was assigned to NXERA PHARMA UK Ltd. (Cambridge, Great Britain).
"Triazolone compounds" was invented by Giles Albert Brown (Cambridge, Great Britain), Miles Stuart Congreve (Cambridge, Great Britain), Stephen Philippe Andrews (Royston, Great Britain), Jonathan Stephen Mason (Cambridge, Great Britain), Francesca Deflorian (Cambridge, Great Britain) and Nigel Alan Swain (Cambridge, Great Britain).
According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are triazalone compounds of Formula (I): and pharmaceutically acceptable salts thereof. Methods of making and using compounds of Formula (I) are also described. Compounds o...